Skip to main content
SpringerLink
Log in

The effect of tolvaptan on kidney function in patients with autosomal dominant polycystic kidney disease

  • Letter to the Editor
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 19 November 2015

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Muto S, Kawano H, Higashihara E, Narita I, Ubara Y, Matsuzaki T, et al. The effect of tolvaptan on autosomal dominant polycystic kidney disease patients: a subgroup analysis of the Japanese patient subset from TEMPO 3:4 trial. Clin Exp Nephrol. 2015. doi:10.1007/s10157-015-1086-2.

    Google Scholar 

  2. Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, et al. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367:2407–18.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Kawada T. Validating GFR estimating samples with clinical outcomes. Am J Kidney Dis. 2014;63:859.

    Article  PubMed  Google Scholar 

  4. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.

    Article  CAS  PubMed  Google Scholar 

  5. Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S. Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis. 2010;56:32–8.

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The author has indicated no financial support. The author has declared that no conflict of interest exists.

Author information

Authors and Affiliations

  1. Department of Hygiene and Public Health, Nippon Medical School, 1-1-5 Sendagi, Bunkyo-Ku, Tokyo, 113-8602, Japan

    Tomoyuki Kawada

Authors
  1. Tomoyuki Kawada
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tomoyuki Kawada.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kawada, T. The effect of tolvaptan on kidney function in patients with autosomal dominant polycystic kidney disease. Clin Exp Nephrol 20, 147–148 (2016). https://doi.org/10.1007/s10157-015-1134-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-015-1134-y

Keywords

Search

Navigation